Meletios Therapeutics is a biotech company that develops antiviral molecules for unmet emergency medical needs.
Meletios Therapeutics is an operator of a biotechnology company intended to fulfill the medical need for antiviral molecules against current and emerging diseases. The company offers antiviral drugs by targeting host mechanisms that are hijacked by viruses, enabling healthcare institutions to treat a range of pathologies.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 2, 2022 | Grant | €2.50M | 1 | European Innovation Council | — | Detail |
Nov 2, 2022 | Private Equity(PE) | €2.70M | 1 | European Innovation Council | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
European Innovation Council | Yes | Grant |